300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Malaysia
Latvia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
Tanzania
India
El Salvador
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Argentina
Qatar
Spain
Bangladesh
Angola
Europe
Cyprus
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Bolivia
Jersey
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Bahrain
Bahamas
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Cambodia
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Martin Suter, Angel Investor

Martin Suter

Angel Investor

Halifax, Canada

Martin Suter is a angel investor in Halifax focused on Nutrition and Health Care. Martin Suter is based out of Halifax, Nova Scotia. Martin previously worked at Anheuser-Busch InBev as a VP, eCommerce (North America Zone). Martin Suter attended the University of Ottawa. Martin Suter has certified the technology negotiation.

Total investments:
3
Last investment:
Lead investor:
100%

Last updated:

Industries Martin Suter invests in

NutritionHealth CareLife ScienceOrganic FoodBiotechnology

Stages Martin Suter invests in

AngelFunding RoundPrivate Equity

Countries Martin Suter invests in

GermanyUnited States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Nutrition 1 (33%)
  • Health Care 1 (33%)
  • Life Science 1 (33%)
  • Organic Food 1 (33%)
  • Biotechnology 1 (33%)

Stage

  • Angel 1 (33%)
  • Funding Round 1 (33%)
  • Private Equity 1 (33%)

Country

  • Germany 1 (33%)
  • United States 1 (33%)

Investments

CompanyDescriptionRoundLinks
AfreeGems AfreeGems
AfreeGems Organic nuts of the highest quality, organic saffron, nut butter, coffee, vanilla beans, and cocoa beans. The Food Gems of Africa are lovingly created for you by eleven partner companies. Angel / Jul 31, 2023
Prolacta Bioscience Prolacta Bioscience
Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill,premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products. $35M / Dec 06, 2016
ATS Medical ATS Medical
ATS Medical, doing business as Medtronic ATS Medical, Inc., is a medical device manufacturer that specializes in products for cardiovascular surgery. Mechanical heart valves, aortic valve graft prostheses, and other cardiovascular accessories are available from the company. Medtronic ATS Medical markets and distributes its products to thehealthcare industry worldwide.ATS Medical was acquired by Medtronic on August 12, 2010 Private Equity

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Malaysia
Latvia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
Tanzania
India
El Salvador
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Argentina
Qatar
Spain
Bangladesh
Angola
Europe
Cyprus
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Bolivia
Jersey
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Bahrain
Bahamas
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Cambodia
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Martin Suter invest in?

Martin Suter invests primarily in Nutrition, Health Care and Life Science startups, most often at Angel and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Martin Suter?

Public channels for Martin Suter include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Martin Suter last invest?

The most recent investment recorded for Martin Suter closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Martin Suter Martin Suter Find email